Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC Jul 24, 2025 05:45PM

Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC Jul 21, 2025 05:33PM

Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC Jul 21, 2025 05:28PM

Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC Jul 15, 2025 08:18PM

Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC Jul 9, 2025 08:06PM

Jul 7, 2025 06:02PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 26, 2025 05:10PM Form 4 Passage BIO, Inc. For: Jun 24 Filed by: ORBIMED ADVISORS LLC
Jun 24, 2025 06:49PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Apr 25, 2025 07:48PM Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Apr 24, 2025 05:39PM Form 4 Passage BIO, Inc. For: Apr 24 Filed by: ORBIMED ADVISORS LLC
Apr 17, 2025 06:11PM Form 4 Passage BIO, Inc. For: Apr 15 Filed by: ORBIMED ADVISORS LLC
Apr 15, 2025 05:40PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 14, 2025 05:17PM Form 4 Passage BIO, Inc. For: Jan 10 Filed by: ORBIMED ADVISORS LLC
Jan 8, 2025 06:10PM Form 4 Passage BIO, Inc. For: Jan 06 Filed by: ORBIMED ADVISORS LLC
Jan 6, 2025 04:57PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 26, 2024 04:34PM Form 4 Passage BIO, Inc. For: Dec 20 Filed by: ORBIMED ADVISORS LLC
Dec 26, 2024 04:31PM Form SCHEDULE 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 11, 2024 05:33PM Form 4 Passage BIO, Inc. For: Dec 09 Filed by: ORBIMED ADVISORS LLC
Dec 6, 2024 07:08PM Form 4 Passage BIO, Inc. For: Dec 04 Filed by: ORBIMED ADVISORS LLC
Dec 4, 2024 07:03PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 23, 2024 04:52PM Form 4 Passage BIO, Inc. For: Sep 19 Filed by: ORBIMED ADVISORS LLC
Sep 18, 2024 06:38PM Form 4 Passage BIO, Inc. For: Sep 16 Filed by: ORBIMED ADVISORS LLC
Sep 16, 2024 08:37PM Form 144 Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Apr 12, 2024 05:35PM Form SC 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 29, 2023 04:42PM Form 4 Passage BIO, Inc. For: Jun 27 Filed by: ORBIMED ADVISORS LLC
Jun 29, 2023 04:37PM Form SC 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
May 5, 2022 05:33PM Form 4 Passage BIO, Inc. For: May 03 Filed by: ORBIMED ADVISORS LLC
May 5, 2022 05:21PM Form 4/A Passage BIO, Inc. For: Jan 20 Filed by: ORBIMED ADVISORS LLC
May 5, 2022 05:14PM Form SC 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 24, 2022 04:44PM Form 4 Passage BIO, Inc. For: Jan 20 Filed by: ORBIMED ADVISORS LLC
Jan 20, 2022 06:04PM Form 4 Passage BIO, Inc. For: Jan 14 Filed by: ORBIMED ADVISORS LLC
Jan 13, 2022 07:38PM Form 4 Passage BIO, Inc. For: Jan 11 Filed by: ORBIMED ADVISORS LLC
Jan 28, 2021 01:48PM Form SC 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 9, 2020 04:54PM Form SC 13D Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 27, 2020 08:10PM Form 3 Passage BIO, Inc. For: Feb 27 Filed by: ORBIMED ADVISORS LLC

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed